Quick Answer
Yubo International Biotech Ltd reported Operating Income of -$1.19 million for fiscal year 2025.
Yubo International Biotech Ltd Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$1.19M | +32.9% |
| 2024 | -$1.77M | -48.1% |
| 2023 | -$1.19M | +0.9% |
| 2022 | -$1.21M | +21.9% |
| 2021 | -$1.54M | -116.8% |
| 2020 | -$711.8K | -2354.5% |
| 2020 | -$29.0K | +39.6% |
| 2019 | -$48.0K | +17.2% |
| 2018 | -$58.0K | +61.1% |
| 2017 | -$149.0K | -136.5% |
| 2016 | -$63.0K | -8.6% |
| 2015 | -$58.0K | -5.5% |
| 2014 | -$55.0K | +8.3% |
| 2013 | -$60.0K | -27.7% |
| 2012 | -$47.0K | +41.2% |
| 2011 | -$80.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$310.1K | +41.8% | -24.2% |
| June 30, 2025 | -$249.7K | +46.9% | +46.6% |
| March 31, 2025 | -$467.3K | -14.1% | +12.3% |
| September 30, 2024 | -$532.8K | -8394.6% | -13.2% |
| June 30, 2024 | -$470.4K | -28.1% | -14.9% |
| March 31, 2024 | -$409.4K | -29.3% | -6474.3% |
| September 30, 2023 | $6.4K | +102.7% | +101.7% |
| June 30, 2023 | -$367.3K | +25.3% | -16.0% |
- Yubo International Biotech Ltd showed an increase of +32.9% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, Yubo International Biotech Ltd’s operating income has declined by 1384.6% (from -$80.0 thousand to -$1.19 million).
- The most recent figure is from Yubo International Biotech Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: